fcr001

Cell therapyexperimental

Clinical trial activity

2 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Jul 31, 2019 (NCT03995901)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 3 Sponsor(trial)

2020s

  1. Jan 1, 2021

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetTissue restoration

    tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05098145Phase 1/Phase 2 (Phase 2)Nov 30, 2021Talaris Therapeutics
NCT03995901Phase 3Jul 31, 2019Talaris Therapeutics
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Talaris TherapeuticsFor profit2222019
1 organizations
Page 1 / 1